Ovation Science Inc.
OVAT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 34.86% | -10.81% | -56.81% | -56.83% | -45.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.86% | -10.81% | -56.81% | -56.83% | -45.35% |
| Cost of Revenue | 1,304.76% | 1,040.00% | 1,700.00% | 328.13% | -99.69% |
| Gross Profit | -10.34% | -42.96% | -83.80% | -68.83% | 110.57% |
| SG&A Expenses | -12.44% | -14.41% | -7.35% | -4.84% | -13.98% |
| Depreciation & Amortization | -8.33% | -25.00% | -42.86% | -53.85% | -61.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.16% | -18.59% | -8.77% | -9.66% | -55.88% |
| Operating Income | 22.88% | 19.69% | -0.36% | 0.87% | 56.77% |
| Income Before Tax | 22.31% | 21.15% | -7.10% | 1.47% | 69.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.31% | 21.15% | -7.10% | 1.47% | 69.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.31% | 21.15% | -7.10% | 1.47% | 69.52% |
| EBIT | 22.88% | 19.69% | -0.36% | 0.87% | 56.77% |
| EBITDA | 22.94% | 19.66% | -0.69% | 0.40% | 56.75% |
| EPS Basic | 31.50% | 26.60% | -1.03% | 3.85% | 69.60% |
| Normalized Basic EPS | 30.16% | 24.41% | -4.13% | 1.54% | 55.94% |
| EPS Diluted | 31.50% | 26.60% | -1.03% | 3.85% | 69.60% |
| Normalized Diluted EPS | 30.16% | 24.41% | -4.13% | 1.54% | 55.94% |
| Average Basic Shares Outstanding | 12.32% | 7.32% | 7.32% | 3.22% | 0.00% |
| Average Diluted Shares Outstanding | 12.32% | 7.32% | 7.32% | 3.22% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |